Herantis Pharma to host a R&D update webinar on January 19, 2023
Herantis Pharma Plc, Press release, 12 January 2023 at 9:00 AM EEST Link to the R&D update webinar (14:00-15:00 EET/13:00-14:00 CET): Click Here to Register Herantis Pharma Plc (“Herantis”), an innovative biotech company developing new disease-modifying therapies for Parkinson’s disease, will host an R&D update webinar on Thursday January 19th, 2023, for investors, analysts, media and for anyone interested in Herantis and our HER-096 program for Parkinson’s disease. The agenda for Herantis’ R&D update webinar: